Award
Delivery Order #SPE2DP26F2975
Delivery Order for Oxymetazoline Hydro from DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$6.04
Ceiling
$6.04
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Feb 23, 2026
Identifier
SPE2DP26F2975
NAICS
424210
This award is a delivery order contract, issued under an existing definitive indefinite delivery vehicle (IDV) pharmaceutical supply contract awarded to DMS Pharmaceutical Group Inc. The recipient, DMS Pharmaceutical Group Inc., is a specialized distributor of pharmaceutical products, tasked with supplying critical drug inventories to federal health agencies. The contract specifically procures Oxymetazoline Hydro, a medication used for nasal decongestion, reflecting its importance in maintaining essential pharmaceutical supplies. The scope of work encompasses the timely delivery of this product within a short, clearly defined period of performance in early 2026, ensuring the agency's immediate operational needs are met. This delivery order complements the broader long-term contract that supports continuous availability of various pharmaceuticals. While original procurement was competitively structured under the parent IDV contract, this particular order leverages that framework for efficient fulfillment. The place of performance is located in Park Ridge, Illinois, demonstrating the geographic sourcing of the pharmaceutical supply. Overall, this award plays a significant role in sustaining ongoing public health initiatives by ensuring access to specific vital medications within concise timelines.
Description
8511936315!OXYMETAZOLINE HYDRO